OpenAI has absorbed a drug-development coordination startup and folded it into Rosalind, its life-sciences model family.
The biotech hunts drugs in plants and microbes rather than in a synthesis lab, and now has a…
Insilico Medicine has released an open longevity toolkit in Cell, pairing a benchmark with small models that beat…
The generative AI biotech posts $35.5M net profit on a first-half revenue surge.
Stanford's 37,000-agent virtual biotech designed a lung cancer drug that Merck independently developed and validated.